Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAN: Intravenous Nicorandil in Acute STEMI Patients Undergoing Primary PCI
NCT04665648Phase 4Completed
- Sponsor
- Fudan University
- Start
- Jun 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nicorandil in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Fudan University. Primary endpoint: Major adverse cardiac events at 12 months. Started Jun 2021; status: completed.
02
Drugs
nicorandil
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04665648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04665648.